TCRR

Artal Group’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-750,000	Closed	-$1.13M	–	136
2023 Q1	$1.13M	Hold	750,000	–	–	0.07%	93
2022 Q4	$749K	Hold	750,000	–	–	0.04%	105
2022 Q3	$1.35M	Hold	750,000	–	–	0.06%	98
2022 Q2	$2.18M	Hold	750,000	–	–	0.12%	89
2022 Q1	$2.07M	Hold	750,000	–	–	0.09%	110
2021 Q4	$3.5M	Hold	750,000	–	–	0.09%	111
2021 Q3	$6.38M	Hold	750,000	–	–	0.14%	97
2021 Q2	$12.3M	Hold	750,000	–	–	0.25%	74
2021 Q1	$16.6M	Buy	750,000 +250,000	+50%	+$5.52M	0.29%	64
2020 Q4	$15.5M	Hold	500,000	–	–	0.33%	64
2020 Q3	$10.2M	Buy	500,000 +150,000	+43%	+$3.05M	0.25%	66
2020 Q2	$5.38M	Sell	350,000 -50,000	-13%	-$768K	0.15%	86
2020 Q1	$3.1M	Hold	400,000	–	–	0.13%	78
2019 Q4	$5.71M	Sell	400,000 -71,846	-15%	-$1.03M	0.22%	59
2019 Q3	$7.09M	Sell	471,846 -18,154	-4%	-$273K	0.28%	51
2019 Q2	$7.01M	Hold	490,000	–	–	0.28%	58
2019 Q1	$8.54M	Buy	+490,000	New	+$8.54M	0.35%	47